Young adults and MS
Multiple sclerosis is the commonest neurological disease affecting young adults. In patients under 30, treatment needs to be adjusted accordingly.
FIGHTing MS THROUGH RESEARCH
Multiple sclerosis is the commonest neurological disease affecting young adults. In patients under 30, treatment needs to be adjusted accordingly.
Multiple sclerosis is a chronic inflammatory disease of the central nervous system that affects over two million people worldwide. Patients may suffer from a wide range of disabling complaints which are not always easy to treat. Although cannabis is best known as a psychoactive recreational drug, it is also increasingly associated with a variety of positive medical effects.
The two major research pathways that could change the future of people with multiple sclerosis, confirm themselves and a life where MS becomes a treatable and controllable condition comes a step closer.
There are many ways to support research: on the occasion of a wedding, a birthday, a neighbors' party, a BBQ, being sponsored during a race or a walk. It's all up to you: our "Action" platform is waiting for you here.
The 104 runners of the Charcot team of the 20 k - Brussels 2019, set an example: together they raised enough money to fund 155 days of research in multiple sclerosis! The next edition of the 20 km will take place on May 31, 2020 and registration will begin on December 15, 2019.
Fill in your inscription today and join the Charcot Team during the 20km off Brussels on May 19, 2019. It will be a perfect day and you will be helping the MS-Research.
13 500 patients are counting on this research and thank you.
